Tocagen (TOCA) Misses Q2 EPS by 4c, Revenues In-Line

Tocagen (NASDAQ: TOCA) reported Q2 EPS of ($0.56), $0.04 worse than the analyst estimate of ($0.52). Revenue for the quarter came in at $10 thousand versus the consensus estimate of $10 thousand.

For earnings history and earnings-related data on Tocagen (TOCA) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• BofA turns S&P 500 signals from red to yellow: What to buy now
• Raymond James on Malibu Boats (MBUU): 'continued soft retail environment'